Shares of Medtronic (MDT 1.69%) climbed as much as 3.3% early Tuesday, and then settled to close up around 1.7%, after the medical-device company announced strong fiscal third-quarter results and impressive forward guidance.On Medtronic's "solid execution," durable growthFor its fiscal third-quarter 2024, ended Jan. 26, Medtronic's revenue grew 4.7% year over year (4.6% organically) to $8.089 billion, translating to roughly flat adjusted (non-GAAP) earnings of $1.728 billion, or $1.30 per share -- though th ...

Medtronic plc (MDT) reported adjusted earnings per share (EPS) of $1.30 in third-quarter fiscal 2024, in line with the year-ago quarter’s EPS. The figure beat the Zacks Consensus Estimate by 3.2%.Without certain one-time adjustments — including restructuring and associated costs, amortization and acquisition-related costs, among others — GAAP EPS were 99 cents, up 7.6% from the year-ago quarter’s reported figure.Total RevenuesWorldwide revenues in the reported quarter grossed $8.09 billion, up 4.7% year ove ...

Key TakeawaysBetter-than-expected sales of heart and diabetes devices helped Medtronic beat fiscal third-quarter profit and sales estimates.The medical devices firm also raised its full-year outlook for the current fiscal year that will end in late April.Medtronic said it was exiting its money-losing ventilator business and combining the remaining parts of its Patient Monitoring and Respiratory Interventions division into one unit.Shares of Medtronic PLC (MDT) gained Tuesday after the medical technology fir ...

Medtronic plc (NYSE:MDT) Q3 2024 Earnings Conference Call February 20, 2024 8:00 AM ET Company Participants Ryan Weispfenning - Vice President and Head, Investor Relations Geoff Martha - Chairman and Chief Executive Officer Karen Parkhill - Chief Financial Officer Brad Welnick - Vice President, Investor Relations Sean Salmon - Executive Vice President and President, Cardiovascular Portfolio Que Dallara - Executive Vice President and President, Diabetes Mike Marinaro - Executive Vice President and President, ...

For the quarter ended January 2024, Medtronic (MDT) reported revenue of $8.09 billion, up 4.7% over the same period last year. EPS came in at $1.30, compared to $1.30 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $7.95 billion, representing a surprise of +1.73%. The company delivered an EPS surprise of +3.17%, with the consensus EPS estimate being $1.26.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they ...

Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 3.17%. A quarter ago, it was expected that this medical device company would post earnings of $1.18 per share when it actually produced earnings of $1.25, delivering a surprise of 5.93%.Over the last four quarters, the co ...

SOPA Images/LightRocket via Getty Images Introduction Medical devices remain a very stable business within the healthcare sector, even in times of economic uncertainty. Medical devices can be a suitable investment with fluctuating markets and economic cycles due to macro data that postpone the anticipated interest rate decrease. This segment is stable due to the constant demand for market medical procedures, thus making it more stable. I believe companies within this b sector that lead innovation are pa ...

Xinhua News Agency/Xinhua News Agency via Getty Images Investment thesis Medtronic (NYSE:MDT) has a vibrant history and is a member of the S&P 500 dividend aristocrats, thanks to its 46 years of dividend increases in a row. The stock had a challenging last five years because of stagnating profitability and intensifying competition in the healthcare industry. Nevertheless, the management exhibits robust adaptability with its efficiency strategies, resulting in notable enhancements in profitability metrics fo ...

Medtronic (MDT) closed the latest trading day at $83.68, indicating a +0.11% change from the previous session's end. The stock lagged the S&P 500's daily gain of 0.96%. Meanwhile, the Dow gained 0.4%, and the Nasdaq, a tech-heavy index, added 1.3%.Prior to today's trading, shares of the medical device company had lost 3.41% over the past month. This has lagged the Medical sector's gain of 1.18% and the S&P 500's gain of 3.69% in that time.The investment community will be paying close attention to the earnin ...

Analysts on Wall Street project that Medtronic (MDT) will announce quarterly earnings of $1.26 per share in its forthcoming report, representing a decline of 3.1% year over year. Revenues are projected to reach $7.95 billion, increasing 2.9% from the same quarter last year.Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.Before a compan ...